Zhavoronkov and senomorphics: INS018_055 as TNIK kinase inhibitor
Alex Zhavoronkov is linked to the senomorphics class through work on INS018_055, a TNIK kinase inhibitor classified as a senomorphic agent because it reduced SASP, the senescence-associated secretory phenotype.
The work "AI-Driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic Agent" classifies INS018_055 as a senomorphic agent on mechanistic grounds: the drug reduced SASP, the senescence-associated secretory phenotype. Alex Zhavoronkov is linked to this work.
Senomorphics suppress harmful phenotypes of senescent cells; the cells themselves may remain viable. INS018_055 acts through TNIK kinase inhibition. Reported consequences: SASP reduction, attenuation of senescent-cell accumulation in experimental models, and modulation of TGF-beta-linked signaling programs.
Zhavoronkov's exact role in this research could not be established from the available data. The same is true for the experimental models, effect sizes, development stage, and independent validation of INS018_055's reported senomorphic activity.
The edge surfaces a concrete mechanistic criterion that places a named compound inside an intervention class, and it connects a high-profile AI drug-discovery figure to a geroscience concept that is actively investigated by multiple projects in the graph. The INS018_055 / TNIK / SASP chain gives the reader something specific to follow rather than a vague association.